Female BRCA1/2 PV carriers face a lifetime risk of roughly 70% for breast cancer (BRCA1: 95% confidence interval (CI) 65–79; BRCA2 95% CI 61–77). This evidence concerns the gene BRCA2 and breast carcinoma.